Rating History for Sagimet Biosciences Inc (SGMT) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/24/2026 | Andrea Newkirk | New Coverage | Sell (N/A) |
7.00 (N/A) |
11.09 (9.99) |
-9.92% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/24/2026 | Andrea Newkirk | New Coverage | Sell (N/A) |
7.00 (N/A) |
11.09 (9.99) |
-9.92% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||